
Keywords: 3- (4،5-dimethylthiazol-2-yl) -2،5-difenyltetrazolium bromide; DMSO; Dimethylsulfoxide; MEF2C; Myocyte enhancer factor 2; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PDT; Population doubling time; Primary myoblast cell culture; Cryopreserved tissue; Skeletal muscle biopsy; Neuromuscular disorde